Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m
The company anticipates the deal to positively impact operating income from fiscal 2028 onwards.
Drug Manufacturers
NorthX Biologics and Demeetra collaborate on GMP manufacturing and CLD
AbbVie announces $380m investment in North Chicago API facilities
AbbVie’s $100bn deal aligns drug pricing with domestic manufacturing goals
Apotex and Grünenthal sign deal for Nebido Canadian distribution
Why pharma manufacturers are still investing in Europe
Eli Lilly selects Pennsylvania for $3.5bn manufacturing site of obesity drugs
FDA’s new scheme to boost US manufacturing commences despite uncertainty
